Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

BACKGROUND AND OBJECTIVE: Certain patients with heart failure (HF) are unable to tolerate spironolactone therapy due to hyperkalemia. Patiromer is a novel agent used to treat hyperkalemia and has been shown to be efficacious, safe, and well-tolerated. The potential clinical outcomes and economic val...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pharmacoeconomics
Главные авторы: Bounthavong, Mark, Butler, Javed, Dolan, Chantal M., Dunn, Jeffrey D., Fisher, Kathryn A., Oestreicher, Nina, Pitt, Bertram, Hauptman, Paul J., Veenstra, David L.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer International Publishing 2018
Предметы:
Original Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6244629/
https://ncbi.nlm.nih.gov/pubmed/30194623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-018-0709-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы